{"id":"W4385751567","doi":"10.1093/jnci/djad155","title":"Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors","year":2023,"lang":"en","type":"article","venue":"JNCI Journal of the National Cancer Institute","topic":"Genital Health and Disease","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health","keywords":"Medicine; Nivolumab; Common Terminology Criteria for Adverse Events; Penile cancer; Internal medicine; Pembrolizumab; Oncology; Interquartile range; Adverse effect; Ipilimumab; Response Evaluation Criteria in Solid Tumors; Cancer; Clinical trial; Phases of clinical research; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005997967,0.0002619824,0.0003515716,0.001196606,0.0001763944,0.0006698217,0.0002657218,0.0003271964,0.0009003166],"category_scores_gemma":[0.006765039,0.00008250888,0.0004376466,0.001776602,0.0004867309,0.0003267621,0.0004777735,0.0003770706,0.0002479356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004445986,"about_ca_system_score_gemma":0.0009236641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009913349,"about_ca_topic_score_gemma":0.001062544,"domain_scores_codex":[0.9976842,0.0007262423,0.0002899485,0.000184763,0.0009998825,0.0001149349],"domain_scores_gemma":[0.9855353,0.003412378,0.006734358,0.0005104974,0.003180647,0.0006268518],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005148785,0.00008101587,0.9006827,0.000546763,0.0004056449,0.0002483162,0.0002342408,0.0003954975,0.001106804,0.0001146521,0.003493496,0.09217592],"study_design_scores_gemma":[0.0001218576,0.001670376,0.9720159,0.0004578903,0.0006202093,0.002142453,0.0003218473,0.0003955295,0.002014352,0.000148644,0.02006526,0.00002576126],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9146907,0.06473507,0.001224147,0.003723247,0.0001639603,0.0001413216,0.004786659,0.00008499209,0.01044994],"genre_scores_gemma":[0.9837332,0.01219549,0.0003137677,0.0008822959,0.00025107,0.0000419328,0.002198562,0.00001193133,0.0003717103],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005997967,"threshold_uncertainty_score":0.0317207,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03154213775347712,"score_gpt":0.3521227347874381,"score_spread":0.3205805970339609,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}